Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
AGS |
Human gastric adenocarcinoma cell line | ATCC CRL-1739 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | A. Rocco, et al., Lab. Investigation, 2012, 92: 1407–1418, doi:10.1038/labinvest.2012.100 | Link | |
AGS-Gr |
Human gastric adenocarcinoma cell line | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | L.-K. M. Selvik et al., PLoS ONE, 2014, 9(11): e112485, doi:10.1371/journal.pone.0112485 | Link | ||
AGS-Gr |
Human gastric adenocarcinoma cell line | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | T. S. Steigedal et al., In Vitro Cell. Dev.Biol. - Animal, 2013, 49: 162–169, DOI 10.1007/s11626-013-9588-2 | Link | ||
AGS-Gr |
Human gastric adenocarcinoma cell line | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | S. Bhandari et al., Biochem. and Biophys. Res. Commun., 2016, 475: 119-124 | |||
ASPC-1 |
Human pancreas carcinoma cell line | ATCC CRL-1682 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | L. Qin et al., Oncotarget, 2016, 7 (14): 17726-17736 | Link | |
ASPC-1 |
Human pancreas carcinoma cell line | ATCC CRL-1682 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | L. Qin, PhD Thesis, 2014, Indiana University | ||
BON |
pancreatic neuroendocrine tumor cell line | Human | unknown | cell line | siRNA | Metafectene SI | publication | X. Zhang et al., J. Cell Biol., 2017, doi.org/10.1083/jcb.201702099 | Link | ||||
BON |
Human pancreatic neuroendocrine tumor cell line | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | X. A. Zhang et al., Bio Protoc., 2018, 8 (1): doi:10.21769/BioProtoc.2680 | Link | ||
BON |
Human pancreatic neuroendocrine tumor cell line | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | E. Crummy et al., J. Biol. Chem., 2019, doi/10.1074/jbc.RA119.007504 | Link | ||
BON |
pancreatic neuroendocrine tumor cell line | Human | unknown | cell line | siRNA | high troughput application | Metafectene SI | publication | X. Zhang et al., J. Cell Biol., 2017, doi.org/10.1083/jcb.201702099 | Link | |||
BT-20 |
Human breast cancer cell line | ATCC HTB-19 | Human | breast | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | M. Endres et al., Oncotarget, 2016, 7(39): 64244-64259 | Link | |
BT549 |
Human mammary gland cells | ATCC HTB-122 | Human | breast | unknown | adherent | siRNA | RNA-Interference | Metafectene SI | application note | ![]() |
||
BxPC3 |
Human pancreatic adenocarcinoma cell line | ATCC CRL-1687 | Human | digestive organs | cell line | adherent | siRNA | Metafectene PRO | publication | Y. Chen et al., Mol. Cancer Res., 2017, 15 (4): 418-28, DOI: 10.1158/1541-7786.MCR-16-0366 | |||
C4-2 |
Human prostate carcinoma cell line (derivat of LNCaP) | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | K. S. R. Sastry et al., J. Biol. Chem., Jul 2006; 281: 20891 - 20901 | Link | ||
CAF |
Human carcinoma associated fibroblasts | Human | digestive organs | primary cell | adherent | siRNA | RNA-Interference | Metafectene | publication | A. Min et al., J. Biochem. Molecular Toxicology, 2015, 29(2): 70-76; DOI 10.1002/jbt | |||
CCD 841 CoTr |
Human normal colon epithel cell line | ATCC CRL-1807 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | L. M. Williams, Dissertation, 2014, Royal College of Surgeons in Ireland | Link | |
CCD 841 CoTr |
Human normal colon epithel cell line | ATCC CRL-1807 | Human | digestive organs | cell line | adherent | siRNA | cotransfection (plasmid/siRNA) | Metafectene | publication | L. M. Williams, Dissertation, 2014, Royal College of Surgeons in Ireland | Link | |
CD4+ T cells |
Human CD4+ T cells | Human | immune system | suspension | siRNA | RNA-Interference | Metafectene PRO | publication | J.-S. Chung et al., Eur. J. Immunol., 2011,41: 1794–1799, DOI 10.1002/eji.201041233 | ||||
CMel-2 |
Human primary superficial spreading melanoma cells | Human | skin | primary cell | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | I. Venza et al., Int. Immunopharmacol., 2014, 21: 439–446; doi.org/10.1016/j.intimp.2014.05.024 | |||
D54 |
Human brain glioblastoma cell line | Human | brain | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | P. D’Arrigo et al., Cell Death Discovery, 2019, 5:137, doi.org/10.1038/s41420-019-0216-0 | Link | ||
D54 |
Human brain glioblastoma cell line | Human | brain | cell line | adherent | siRNA | cotransfection (plasmid/siRNA) | K2 Transfection System | publication | P. D’Arrigo et al., Cell Death Discovery, 2019, 5:137, doi.org/10.1038/s41420-019-0216-0 | Link | ||
Daoy |
Human desmoplastic cerebellar medulloblastoma cell line | ATCC HTB-186 | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | M.C. Burger et al., Int. J. of Oncology, 2012, 41: 235-241, DOI: 10.3892/ijo.2012.1446 | Link | |
DU145 |
Human prostate cancer cell line, derived from metastatic site: brain | ATCC HTB-81 | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | K. J. Choi et al., Cancer Res., Apr 2007; 67: 3654 - 3662 | Link | |
EJ138 |
Human bladder carcinoma cell line | ECACC 85061108 | Human | urinary system | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | M.C. Burger et al., Int. J. of Oncology, 2012, 41: 235-241, DOI: 10.3892/ijo.2012.1446 | Link | |
FO2-98hTERT |
Human ATR mutated Seckel hTERT immortalized fibroblasts | Human | unknown | unknown | adherent | siRNA | RNA-Interference | Metafectene | publication | T. Stiff et al., Hum. Mol. Genet., Apr 2016; 25: 1574 - 1587 | Link |